MedTrace Logo

Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection

NCT02126267 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2014-04-29

No results posted yet for this study

Summary

Evaluate and compare the effectiveness in a clinical and microbial perspective one stage full-mouth disinfection technique in relation to scaling and root planing per quadrant associated with chlorhexidine or azithromycin.

Conditions

  • Periodontal Disease
  • Chronic Periodontitis

Interventions

PROCEDURE

Scaling and root planing

Scaling procedures were performed per quadrant (30 min. per quadrant) at weekly intervals between sessions;

PROCEDURE

Full mouth disinfection

Procedures for scaling and root planing were performed in a single stage (24 hours) divided into two sessions (60 min per session) on two consecutive days

DRUG

Chlorhexidine gel and gluconate

application of chlorhexidine (CX) (1%) gel in pockets after scaling, brushing tongue for 1 min. with CX (1%) gel and mouthwash at the beginning and end of each session with CX 0.2% for 30 seconds (with the form of a gargle in the last 10 seconds)

DRUG

Chlorhexidine gluconate solution

Home use fo CX 0.2% for 60 consecutive days after the end of the first session of scaling.

DRUG

Azithromycin

Azithromycin (500 mg) once daily for 3 consecutive days.

Sponsors & Collaborators

  • Federal University of Minas Gerais

    collaborator OTHER

  • Centro Universitario de Lavras

    lead OTHER

Principal Investigators

  • Douglas C Fonseca, Ms · Universitary Center of Lavras

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-02-28
Completion
2014-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02126267 on ClinicalTrials.gov